Accretion/Dilution Versus DCF in a Bolt-On Acquisition
Arbor Group, a TSX-listed industrial acquirer, is evaluating the purchase of Kestrel Fabrication for a $96 million enterprise value (8.0x Kestrel's $12.0 million EBITDA). Kestrel has $20 million of debt costing 5%, depreciation of $3.0 million, capex of $3.5 million, a $0.5 million annual increase in net working capital, and a 25% tax rate. Its free cash flow is expected to be stable, growing at 2% after year 5. Arbor's WACC is 9%. Arbor expects pre-tax synergies of $2.5 million annually, 50% realized in year 1 and 100% thereafter, with $4.0 million of one-time after-tax integration costs in year 1. Arbor has $60 million net income and 30 million shares (EPS $2.00); its share price is $36. Financing options are 6% debt or shares at $36. Arbor's CFO says the deal is "accretive on a debt-financed basis, so it creates value." The board asks for a valuation and a recommendation.
1. Value Kestrel on a standalone basis and with synergies. Compare the result with the $96 million asking price.
Read the worked answer
Standalone free cash flow.
- EBIT: $12.0M − $3.0M = $9.0M
- Tax: $2.25M; NOPAT: $6.75M
- FCF: $6.75M + $3.0M − $3.5M − $0.5M = $5.75M
Standalone DCF.
- Terminal value at year 5: $5.75M × 1.02 ÷ (0.09 − 0.02) = $83.79M
- PV of terminal value: $83.79M ÷ 1.09^5 = $54.45M
- PV of FCF years 1–5: $5.75M × 3.8897 = $22.37M
- Enterprise value: $76.82M
- Equity value: $76.82M − $20.0M debt = $56.82M
Synergy value. After-tax annual synergies: $2.5M × 0.75 = $1.875M.
- Year 1 at 50%: $0.9375M; years 2–5: $1.875M
- PV of years 1–5: $0.9375M ÷ 1.09 + $1.875M × (3.8897 − 0.9174) = $0.86M + $5.57M = $6.43M
- Terminal value at year 5: $1.875M × 1.02 ÷ 0.07 = $27.32M; PV = $17.76M
- Gross synergy value: $24.19M
- Less PV of after-tax integration costs: $4.0M ÷ 1.09 = $3.67M
- Net synergy value: $20.52M
Maximum value. Standalone EV plus net synergies = $76.82M + $20.52M = $97.34M. At a $96M price, Arbor captures only about $1.34M of value, or roughly 1.4% of the purchase price. The deal is not obviously value-destroying, but the margin is thin and depends on achieving the full synergy estimate. A price above about $97.3M would transfer all synergy value to Kestrel's sellers.
2. Compute EPS accretion/dilution under debt and share financing, and critique the CFO's statement that accretion means value creation.
Read the worked answer
Target net income. EBIT $9.0M − interest $1.0M ($20M × 5%) = $8.0M; tax $2.0M; net income $6.0M.
Combined earnings before one-time costs. $60.0M + $6.0M + $1.875M after-tax synergies = $67.875M.
Debt financing at 6%.
- Additional interest: $96M × 6% = $5.76M; after tax $4.32M
- EPS before integration costs: ($67.875M − $4.32M) ÷ 30.0M = $2.118 (accretive 5.9%)
- Including $4.0M after-tax integration costs: ($67.875M − $4.32M − $4.0M) ÷ 30.0M = $1.985 (dilutive 0.7%)
Share financing at $36.
- New shares: $96M ÷ $36 = 2.667M; total shares 32.667M
- EPS before integration costs: $67.875M ÷ 32.667M = $2.078 (accretive 3.9%)
- Including integration costs: ($67.875M − $4.0M) ÷ 32.667M = $1.955 (dilutive 2.2%)
Critique. The CFO is conflating accounting accretion with value creation. Debt financing is accretive before one-time costs mainly because the after-tax cost of debt (4.5%) is below Kestrel's earnings yield ($6.0M ÷ $96M = 6.25%). That is an accounting arbitrage, not evidence that the price is right. The DCF shows only about $1.34M of value creation at $96M, and the deal is dilutive once integration costs are included. Accretion/dilution also ignores the balance sheet, the risk of the acquired debt, and the fact that synergies may not be realized. The board should rely on the DCF and the synergy case, not the EPS table.
3. What price should Arbor be willing to pay, and what deal protections and purchase price allocation issues matter?
Read the worked answer
Walk-away price. On the base-case synergies, the maximum economically justified enterprise value is about $97.3M. Arbor should target a price in the low $90s to retain a margin for synergy shortfall. At $96M, the deal is acceptable only if the synergy estimate is highly credible; at $98M or more, Arbor is overpaying. A price of $90M would leave about $7.3M of value for Arbor, roughly 7.5% of the purchase price.
Deal protections:
- An earn-out or contingent consideration tied to realized synergies or Kestrel's EBITDA, so sellers share the risk.
- A working capital peg and a dollar-for-dollar adjustment, because Kestrel's $0.5M annual working capital increase is a real cash cost.
- Representations and warranties on customer contracts, receivables, environmental liabilities, and related-party arrangements.
- A financing condition or committed financing, because the 6% debt assumption may not hold if leverage rises.
- Retention packages for key operating staff, since the synergies depend on integration.
Purchase price allocation issues: The $96M price must be allocated to fair value of identifiable assets and liabilities, not book values. Fair-value step-ups to PP&E and inventory will increase depreciation/COGS and reduce future earnings. Identifiable intangibles such as customer relationships, technology, and trademarks must be recognized and amortized, with related deferred tax effects. Goodwill is the residual; a large goodwill balance is a signal that the price depends on synergies and growth rather than identifiable assets. Arbor should obtain a valuation of Kestrel's PP&E, intangibles, and contingent liabilities before signing, and should model the post-PPA depreciation and amortization in the accretion analysis.